Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

30 May, 2020, 12:00 BST Guardant360 test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients

According to the data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on 29 May 2020, researchers at Samsung Medical...


29 May, 2020, 20:30 BST CHMP Issues Positive Opinion to Extend Invokana® (Canagliflozin) Indication to Reflect Improved Renal Outcomes in Patients With Diabetic Kidney Disease and Type 2 Diabetes

As the exclusive UK distributor of Invokana® (canagliflozin), Napp Pharmaceuticals Limited today announced that the European Medicines Agency's (EMA) ...


29 May, 2020, 18:27 BST Arcadia Emphasises the Role of Custom Software Development in Global Medical Safety

Where development of vaccines usually takes years, the U.K. could roll out 30 million doses of a Covid-19 vaccine as early as September, according to ...


29 May, 2020, 13:13 BST Alligator Bioscience Presents Novel Supportive Phase I Data at ASCO for its CTLA-4 x OX40 Bispecific Drug Candidate ATOR-1015

Alligator Bioscience (Nasdaq Stockholm: ATORX), announces that the company today presents additional novel data from the ongoing Phase I clinical...


29 May, 2020, 12:00 BST Oncolytics Biotech® Presents Clinical Proof-of-Concept Data in Multiple Myeloma at the ASCO Virtual Annual Meeting

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today...


29 May, 2020, 08:19 BST LifeArc Awards £ 1.5 Million Grant to Vicore Pharma for the VP01 COVID-19 Clinical Study

Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, today announces that...


29 May, 2020, 08:00 BST New Data and Society Guidelines Support Value of Oncotype DX Breast Recurrence Score® Test in Guiding Neoadjuvant Treatment Decisions for Newly Diagnosed Patients

Exact Sciences Corp. today announced results from three studies of the Oncotype DX Breast Recurrence Score® test, presented at the virtual 2020...


29 May, 2020, 06:00 BST World No Tobacco Day, 31St May: Allen Carr's Easyway Celebrates Helping More Than 50 Million Smokers Worldwide

Coinciding with World No Tobacco Day on 31st May 2020, the international publishing agents for Allen Carr's Easyway, have revealed that this...


28 May, 2020, 08:48 BST Seaweed Extract Offers Hope for Influenza A

Australian scientists have revealed that a natural compound found in seaweed may reduce the effects of severe cases of Influenza A. Fucoidan is a...


28 May, 2020, 07:15 BST Oncopeptides Reinitiates Patient Enrollment to the Melflufen Clinical Program Following a Temporary Pause due to the COVID-19 Pandemic

Oncopeptides AB (Nasdaq Stockholm: ONCO) announces that the company starts patient enrollment to its clinical program following the temporary...


27 May, 2020, 14:15 BST Merck and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19

Merck, a leading science and technology company, and Baylor College of Medicine, Houston, Texas, USA, today announced an extension of their ongoing...


27 May, 2020, 13:07 BST Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement with Humanigen for Lenzilumab, Currently in FDA-Approved Phase III Study for COVID-19

Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased ...


27 May, 2020, 12:00 BST Alkermes Highlights New Data From Schizophrenia Portfolio at the American Society of Clinical Psychopharmacology 2020 Annual Meeting

Alkermes plc (Nasdaq: ALKS) today announced plans to present new research from its schizophrenia portfolio at the American Society of Clinical...


27 May, 2020, 08:00 BST Pneumagen Announces £4m Fundraising and Commits to Clinical Trial Development for COVID-19

Pneumagen (Holdings) Ltd, focused on treating infectious diseases by targeting the human glycome, today announced a GBP £4 million investment to...


27 May, 2020, 08:00 BST Cytovation Announces Dosing of First Patient in its Phase I/II CICILIA Trial Investigating CyPep-1 in Patients with Solid Cancers

Cytovation AS ("Cytovation"), a clinical-stage biotechnology company focused on developing CyPep-1, a next-generation lytic immunotherapy, is pleased ...


26 May, 2020, 13:30 BST Arena Completes Full Enrollment of Etrasimod Phase 2 ADVISE Trial for Atopic Dermatitis, Provides Program Updates

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that it has completed full enrollment of the Phase 2b ADVISE trial evaluating etrasimod,...


26 May, 2020, 13:00 BST Orteq® Sports Medicine Announces Publication of 5-year Multi-Center Clinical Data for the Actifit® Meniscal Scaffold in the American Journal of Sports Medicine (AJSM), Receives FDA Breakthrough Device Designation

Orteq Sports Medicine Ltd. (www.orteq.com), a developer of joint preservation solutions for orthopedic patients, announces 5-year, multi center,...


26 May, 2020, 12:00 BST Oncolytics Biotech® Presents Clinical Data Supporting a Predictive Biomarker of Pelareorep Response in Breast Cancer at the ESMO Breast Cancer Virtual Meeting

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today...


26 May, 2020, 09:35 BST Glenmark to Commence New Phase 3 Clinical Trial on Combination of Two Anti-viral Drugs Favipiravir and Umifenovir in Hospitalized Patients of Moderate COVID-19 in India

Glenmark Pharmaceuticals, a global pharmaceutical company, announced a new randomized, open-label study to test the combined efficacy of two...


22 May, 2020, 08:52 BST RDIF and ChemRar Launch Final Stage of Favipiravir Clinical Trial

The Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, and the ChemRar Group today announce the start of the final stage of the...


22 May, 2020, 07:21 BST Oncopeptides Completes Enrollment to the Pivotal Phase 3 Study OCEAN for Relapsed Refractory Multiple Myeloma - 450 Patients Included

Oncopeptides AB (Nasdaq Stockholm: ONCO) announces a successful completion of enrollment in the pivotal phase 3 study OCEAN for the treatment of...


21 May, 2020, 23:01 BST Social Isolation Increases the Risk of Heart Attacks, Strokes, and Death From All Causes, According to Research at the European Academy of Neurology Virtual Congress

Those who are socially isolated are over 40% more likely to have a cardiovascular event, such as a heart attack or stroke, than those who were...


21 May, 2020, 06:00 BST First UK Participant Enters the Largest COVID-19 Interventional Trial in the World Involving 40,000 Frontline Healthcare Workers

Today, 21 May 2020, the first UK frontline NHS worker will be enrolled as a participant into COPCOV, the largest multi-national interventional...


20 May, 2020, 14:18 BST Clinical Research and Development Efforts Booming in Midst of COVID-19 Health Crisis

Fighting the new global pandemic is a top priority in medical research and pharmaceutical development. Hundreds of organizations are working on...


20 May, 2020, 12:00 BST Journal of Clinical Psychiatry Publishes Data from Alkermes' ALPINE Study in Patients With Schizophrenia

Alkermes plc (Nasdaq: ALKS) today announced that data from its phase 3b ALPINE (Aripiprazole Lauroxil and Paliperidone palmitate: INitiation...